Cargando…
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
This study evaluated the prognostic roles of murine double minute 2 (MDM2) and p53 in pancreatic cancer patients treated with gemcitabine-based chemotherapy. A total of 137 advanced or recurrent adenocarcinoma patients who were treated with gemcitabine-based palliative chemotherapy were reviewed, se...
Autores principales: | Yang, Shih-Hung, Lee, Jen-Chieh, Guo, Jhe-Cyuan, Kuo, Sung-Hsin, Tien, Yu-Wen, Kuo, Ting-Chun, Cheng, Ann-Lii, Yeh, Kun-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498069/ https://www.ncbi.nlm.nih.gov/pubmed/28678832 http://dx.doi.org/10.1371/journal.pone.0180628 |
Ejemplares similares
-
Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer
por: Wu, Hsu, et al.
Publicado: (2019) -
ATM/RB1 mutations predict shorter overall survival in urothelial cancer
por: Yin, Ming, et al.
Publicado: (2018) -
GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma
por: Liu, Xun, et al.
Publicado: (2019) -
Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
por: Onken, Julia, et al.
Publicado: (2017) -
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
por: Tseng, Jeng-Sen, et al.
Publicado: (2018)